BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 37140543)

  • 21. Concurrent giant tumoral pseudoangiomatous stromal hyperplasia necessitating bilateral mastectomy.
    Samaila MO; Aliyu HO; Yusufu LM; Abdullahi S
    Ann Afr Med; 2018; 17(2):82-85. PubMed ID: 29536962
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Fine-needle aspiration cytology of pseudoangiomatous stromal hyperplasia of the breast.
    Lui PC; Law BK; Chu WC; Pang LM; Tse GM
    Diagn Cytopathol; 2004 May; 30(5):353-5. PubMed ID: 15108236
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pseudoangiomatous stromal hyperplasia (PASH) of the breast with foci of morphologic malignancy: a case of PASH with malignant transformation?
    Nassar H; Elieff MP; Kronz JD; Argani P
    Int J Surg Pathol; 2010 Dec; 18(6):564-9. PubMed ID: 18611932
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Giant nodular pseudoangiomatous stromal hyperplasia (PASH) of the breast presenting as a rapidly growing tumour.
    Mezzabotta M; Riccardi S; Bonvini S; Declich P; Tavani E; Morandi E
    Chir Ital; 2009; 61(3):369-73. PubMed ID: 19694241
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Fibroepithelial tumours of the breast-a review.
    Lerwill MF; Lee AHS; Tan PH
    Virchows Arch; 2022 Jan; 480(1):45-63. PubMed ID: 34505197
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mammary fibroadenoma and some phyllodes tumour stroma are composed of CD34+ fibroblasts and factor XIIIa+ dendrophages.
    Silverman JS; Tamsen A
    Histopathology; 1996 Nov; 29(5):411-9. PubMed ID: 8951485
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Optimal treatment of pseudoangiomatous stromal hyperplasia of the breast.
    Yoon KH; Koo B; Lee KB; Lee H; Lee J; Kim JY; Park HS; Park S; Kim SI; Cho YU; Park BW
    Asian J Surg; 2020 Jul; 43(7):735-741. PubMed ID: 31669037
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Diagnosis of pseudoangiomatous stromal hyperplasia of the breast: ultrasonography findings and different biopsy methods.
    Choi YJ; Ko EY; Kook S
    Yonsei Med J; 2008 Oct; 49(5):757-64. PubMed ID: 18972596
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pseudoangiomatous Stromal Hyperplasia of the Breast: Multimodality Review With Pathologic Correlation.
    Raj SD; Sahani VG; Adrada BE; Scoggins ME; Albarracin CT; Woodtichartpreecha P; Posleman Monetto FE; Whitman GJ
    Curr Probl Diagn Radiol; 2017; 46(2):130-135. PubMed ID: 26949063
    [TBL] [Abstract][Full Text] [Related]  

  • 30. MRI features of pseudoangiomatous stromal hyperplasia with histopathological correlation.
    Nia ES; Adrada BE; Whitman GJ; Candelaria RP; Krishnamurthy S; Bassett RL; M Arribas E
    Breast J; 2021 Mar; 27(3):242-247. PubMed ID: 33393706
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Does Identifying Whether Pseudoangiomatous Stromal Hyperplasia (PASH) Is Focal or Diffuse on Core Biopsy Correlate With a PASH Nodule on Excision?
    Rosa G; Dawson A; Rowe JJ
    Int J Surg Pathol; 2017 Jun; 25(4):292-297. PubMed ID: 27811185
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mammary pseudoangiomatous stromal hyperplasia composed of predominantly giant cells: an unusual variant.
    Comunoğlu N; Comunoğlu C; Ilvan S; Calay Z; Müslümanoğlu M
    Breast J; 2007; 13(6):568-70. PubMed ID: 17983397
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A novel genomic panel as an adjunctive diagnostic tool for the characterization and profiling of breast Fibroepithelial lesions.
    Sim Y; Ng GXP; Ng CCY; Rajasegaran V; Wong SF; Liu W; Guan P; Nagarajan S; Ng WY; Thike AA; Lim JCT; Nasir NDBM; Tan VKM; Madhukumar P; Yong WS; Wong CY; Tan BKT; Ong KW; Teh BT; Tan PH
    BMC Med Genomics; 2019 Oct; 12(1):142. PubMed ID: 31647027
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pseudoangiomatous stromal hyperplasia and breast cancer risk.
    Degnim AC; Frost MH; Radisky DC; Anderson SS; Vierkant RA; Boughey JC; Pankratz VS; Ghosh K; Hartmann LC; Visscher DW
    Ann Surg Oncol; 2010 Dec; 17(12):3269-77. PubMed ID: 20567920
    [TBL] [Abstract][Full Text] [Related]  

  • 35. MED12 protein expression in breast fibroepithelial lesions: correlation with mutation status and oestrogen receptor expression.
    Tan WJ; Chan JY; Thike AA; Lim JC; Md Nasir ND; Tan JS; Koh VC; Lim WK; Tan J; Ng CC; Rajasegaran V; Nagarajan S; Bay BH; Teh BT; Tan PH
    J Clin Pathol; 2016 Oct; 69(10):858-65. PubMed ID: 27056456
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Columnar cell lesions and pseudoangiomatous hyperplasia like stroma: is there an epithelial-stromal interaction?
    Recavarren RA; Chivukula M; Carter G; Dabbs DJ
    Int J Clin Exp Pathol; 2009 Oct; 3(1):87-97. PubMed ID: 19918332
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Unilateral rapid enlargement of an adolescent breast: pseudoangiomatous stromal hyperplasia in a giant juvenile fibroadenoma.
    Bayramoglu Z; Yılmaz R; Caliskan E; Onder S; Akkavak G; Adaletli I
    Breast J; 2018 Jul; 24(4):648-649. PubMed ID: 29517136
    [No Abstract]   [Full Text] [Related]  

  • 38. Pseudoangiomatous stromal hyperplasia of the breast in two adolescent females.
    Gow KW; Mayfield JK; Lloyd D; Shehata BM
    Am Surg; 2004 Jul; 70(7):605-8. PubMed ID: 15279183
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mutational analysis of MED12 exon 2 in a spectrum of fibroepithelial tumours of the breast: implications for pathogenesis and histogenesis.
    Lien HC; Huang CS; Yang YW; Jeng YM
    Histopathology; 2016 Feb; 68(3):433-41. PubMed ID: 26109290
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Bilateral Diffuse Pseudoangiomatous Stromal Hyperplasia Necessitating Mastectomy.
    Jones VM; Cairns A; Miller-Ocuin J; Steele T; Aguila-Seara G; Ghandili M; LeRoy Coldren D; Marks MW; Howard-McNatt M; Chiba A
    Am Surg; 2022 Aug; 88(8):1919-1921. PubMed ID: 35435015
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.